Breaking News
Get 50% Off 0
Unlock Premium Data: Up to 50% Off InvestingPro CLAIM SALE
Close

Manulife Contrarian Strategy Eq (229002)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.876 -0.000    0.00%
21/06 - Closed. Currency in CNY ( Disclaimer )
  • Morningstar Rating:
  • Total Assets: 124.78M
Type:  Fund
Market:  China
Issuer:  MANULIFE TEDA Fund Mgmt Co.,Ltd
Asset Class:  Equity
Manulife TEDA Contrarian Strategy Equity Fund 1.876 -0.000 0.00%

229002 Holdings

 
Comprehensive information about top holdings and Key Holding Information for the Manulife TEDA Contrarian Strategy Equity Fund (229002) fund. Our Manulife TEDA Contrarian Strategy Equity Fund portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 8.420 8.420 0.000
Stocks 92.370 92.370 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 11.852 18.477
Price to Book 1.506 2.569
Price to Sales 0.892 2.074
Price to Cash Flow 4.717 10.231
Dividend Yield 3.213 2.278
5 Years Earnings Growth 11.903 20.128

Sector Allocation

Name  Net % Category Average
Consumer Cyclical 23.110 9.794
Industrials 21.290 20.829
Technology 11.030 27.316
Financial Services 10.470 6.242
Basic Materials 10.400 9.672
Healthcare 10.030 14.470
Consumer Defensive 5.080 11.188
Communication Services 4.330 4.386
Utilities 2.030 4.241
Energy 2.030 5.406
Real Estate 0.190 3.463

Region Allocation

  • Asia
  • Emerging Markets

Top Holdings

Number of long holdings: 555

Number of short holdings: 1

Name ISIN Weight % Last Change %
  Zijin Mining A CNE100000B24 1.84 17.32 -1.37%
  Ping An Insurance CNE000001R84 1.52 41.67 +0.39%
  WuXi AppTec CNE1000031K4 1.39 40.49 -1.46%
  BYD A CNE100001526 1.37 250.67 -0.33%
  Wanda Cinema Line Corp CNE100001WW1 1.32 12.63 +1.12%
  Hisense Kelon A CNE000000LC9 1.31 37.18 -0.85%
  Nhwa Pharma A CNE100000CG8 1.30 23.73 -2.02%
  Qingdao Haier CNE000000CG9 1.28 29.18 -0.85%
  Fuyao Glass A CNE000000230 1.16 45.17 -0.46%
  Midea Group A CNE100001QQ5 1.10 63.95 -0.81%

Top Equity Funds by MANULIFE Fund Mgmt Co.,Ltd

  Name Rating Total Assets YTD% 3Y% 10Y%
  Manulife TEDA Trsfmtn Opportunity E 3.88B 16.64 -6.97 -
  MANULIFE TEDA RuiZhi WJ Alloc 1.37B -2.53 5.04 -
  TEDA Value Optimization Growth Ind 983.01M 19.12 -4.40 7.15
  MANULIFE TEDA Market Value Selectio 946M 20.02 -5.32 6.75
  TEDA Value Optimization Cycle Ind 710.35M 16.08 4.71 14.07
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

229002 Comments

Write your thoughts about Manulife Contrarian Strategy Eq
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email